Golden State Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$619 Hold
41
﹤0.01% 1527
2026
Q1
$786 Sell
41
-39
-49% -$847 ﹤0.01% 1479
2025
Q4
$1.76K Buy
80
+39
+95% +$704 ﹤0.01% 1410
2025
Q3
$498 Hold
41
﹤0.01% 1571
2025
Q2
$764 Hold
41
﹤0.01% 1459
2025
Q1
$786 Hold
41
﹤0.01% 1454
2024
Q4
$1.48K Buy
+41
New +$1.39K ﹤0.01% 1295

Other funds holding TNDM

Golden State Wealth Management's TNDM Position: Q2 2026 in Review

Golden State Wealth Management held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 41 shares worth $619. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Golden State Wealth Management first reported a position in TNDM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.76K in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Golden State Wealth Management held 41 shares of Tandem Diabetes Care worth $619 as of Q2 2026.
  • Golden State Wealth Management left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1527 holding.
  • Golden State Wealth Management first reported a position in Tandem Diabetes Care in Q4 2024 and has held it in 7 quarters since.
  • Golden State Wealth Management's Tandem Diabetes Care position peaked at $1.76K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.